5FT7XCVardfvyVA4USCDMtMTJH-5F-5F9MCwLk-2526e- 253D%26d%3DDwIGaQ%26c%3DAnw7wKLFSGyH7zEzlqo-zgMRy5HE-AH- SibmOy3H7xE%26&/03Dz3qSdxmlO3zz6GPGylfF- 3_Hq7hsd5IK6Msil28sDI2s%26m%3DICMcMiSv5F7HqY4pQPICPwh7bwGpy3CQPMWkd7Oauvox8%26s%3 DBc6HsIYghP1sVjbZolpXL2OPkD7K7DBf3awq0bZu4Kk%26e%3D> From: < IIME<rnailto:a> Sent: Wednesday, November 11, 2020 1:43 PM To: McGort Glen mailto: Cc: Zelenko, Daniel - mailto Subject: RE: Wednesdays WebEx External Email Glen, >; Giffuni, Danielle (USANYS) We will be joined by two FBI agents who are focusing on the CBP to that we have previously discussed. I expect one of those agents will take the lead on questioning Mr. . The topics we expect to cover include: * The identities of,CBP employees Mr. recalls interacting with Jeffrey Epstein in the Virgin Islands. * Any steps Mr. recalls any CBP employees in the Virgin Islands taking to help Epstein and those traveling with Epstein to enter the country, including any steps that allowed Epstein or those traveling with him to avoid processin,attravelers would normally undergo. * Any favors Mr. recalls Epstein doing for CBP employees in the Virgin Islands, such as trips to Epstein's island. Thanks, Assistant United States Attorney Southern District of New York From: McGorty, Glen ail <mailto:a> Sent: Tuesda November 10, 2020 1:16 PM To: Cc: Zelenko, Daniel mailto Subject: RE: Wednesday's WebEx mailto: >; Giffuni, Danielle (USANYS) --- just wanted to circle back with you in advance of Thursday's meeting. We want to be fully prepared, so if there is any more granularity on this topic (or any additional topic or topics), please let us know. EFTA00022440

Thanks, Glen Glen G. McGorty I Crowell & Moring LLP Managing Partner, New York Office mailto: I https://protect2.fireeye.com/v1/url?k=1c17f113- 438ce9c3- c 0d5f6-0cc47adc5fd8-5058b597bf52a I bacq=l&e=933a0917-9adb-096-b7eb- 545ade9fe2fl&u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps- 3A_protect2.fireeye.com_vl_ur1-3Fk-3Ddc0510d8-2D839e2828-2Ddc02343d-2Daclf6b0176b0- 2Db8578791fe7715138-26q-3D1-26e-3D1d1 e9fd4-2D963c-2D4ffIc-2D9030-2Dfa571a9724ea-26u-3Dhttp- 253A-252F-252Fwww.crowell.com-252F%26d%3DDwIGaQ%26c%3DAnw7wKLFSGyH7zEzlqo- zgMRy5HE-AH-SibmOy3H7xE%26r%3Dz3qSdxmKBzz6GPGylfF- 3_Hq7hsd5IK6Msil28sD12s%26m%3DICMcMiSv5F7HqY4pQPICPwh7bwGpy3CQPMWkd7Oauvox8%26s%3 DhyhWc1K6cwof67C3u4EQVN6OfG3HgDh-nj4sqFL565M%26e%3D <https://protect2.fireeye.com/v1/url? k=2dd899ed-7243a1Id-2ddfbd08-0cc47adc5fd8-86f9811062d02cbd&q=1&e=933a0917-9adb-4b96-b7eb- 545ade9fe2fl &u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps- 3A_protect2.fireeye.com_vl_ur1-3Fk-3D74293fd8-2D2bb20728-2D742e1b3d-2Daclf6b0176b0- 2D73400e2bbab13263-26q-3D1-26e-3D1dle9fd4-2D963c-2D4f0c-2D9030-2Dfa571a9724ea-26u-3Dhttps- 253A-252F-252Furldefense.proofpoint.com-252Fv2-252Fur1-253Fu-253Dhttps-2D3A-5F- 5Fprotect2.fireeye.com-5Fv1-5Fur1-2D3Fk-2D3D3b2c69ca-2D2D64b7513a-2D2D3b2b4d2f- 2D2Daclf6b01744c-2D2D14bc208ec6780fdb-2D26q-2D3D1-2D26e-2D3D83d2ee7c-2D2Db93e-2D2D4e2b- 2D2Daa44-2D2Da878fdb13980-2D26u-2D3Dhttps-2D253A-2D252F-2D252Furldefense.proofpoint.com- 2D252Fv2-2D252Fur1-2D253Fu-2D253Dhttps-2D2D3A-2D5F-2D5Fprotect2.fireeye.com-2D5Fv1-2D5Fur1- 2D2D3Fk-2D2D3Dce2145d1-2D2D2D9lba7c9d-2D2D2Dce266134-2D2D2DOcc47adca7cc- 2D2D2D1c1f9423471e6b37-2D2D26q-2D2D3D1-2D2D26e-2D2D3D6f706ce0-2D2D2De9c6-2D2D2D4b08- 2D2D2Da64c-2D2D2D2f358da88751-2D2D26u-2D2D3Dhttp-2D2D253A-2D2D252F- 2D2D252Fwvvw.crowell.com-2D2D252F-2D2526d-2D253DDwMFAg-2D2526c- 2D253DAnw7wICLFSGyH7zEzlqo-2D2DzgMRy5HE-2D2DAH-2D2DSibm0y3H7xE-2D2526r- 2D253Dz3qSdxmlOEIzz6GPGylfF-2D2D3-2D5FHq7hsd51K6Msil28sD12s-2D2526m-2D253DBxYgAU783n- 2D5FMrr2q5wLWEF-2D2DW5qC1NJ5632-2D2DFFn3TIGQ-2D2526s-2D253D4fUC5zvOQICTIOK6Z0E- 2D2DazkwZ8KF38-2D5FittRICZa6aojQU-2D2526e-2D253D-2526d-253DDwMFAg-2526c- 253DAnw7wICLFSGyH7zEzlqo-2DzgMRy5HE-2DAH-2DSibm0y3H7xE-2526r- 253Dz3qSamICEzz6GPGylfF-2D3-5FHq7hsd51K6Msi128sD12s-2526m- 253DReH187Lo8GfZx7aE2WwyLLYGKETXifodokdng9nMbyQ-2526s-253D0FgxT-2DdmuTbrZ9CL- 2DCHYOCjPM7VVIDNEkPv-2DbC1QAKQ-2526e- 253D%26d%3DDwIGaQ%26c%3DAnw7wKLFSGyH7zEzlqo-zgMRy5HE-AH- Sibm0y3H7xE%26&/03Dz3qSdxmICEzz6GPGylfF- 3_Hq7hsd5IK6Msil28sD12s%26m%3DKMcMiSv5F7HqY4pQPICPwh7bwGpy3CQPMWkd70auvox8%26s%3 DQTWjN5nRFJ9MZVX8XcdPK9i3abuXPvri-HyOlDP-iWE%26e%3D> I Web Bio<https://protect2.fireeye.com/v1/url?k=da7f6cc0-85e45430-da784825-Occ47adc5fd8- 909df02433f457d5&q=l&e=933a0917-9adb-4b96-b7eb- 545ade9fe2fl &u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps- 3A_protect2.fireeye.com_vl_ur1-3Fk-3Da3bbfe7c-2Dfc20c68c-2Da3bcda99-2Daclf6b0176b0- 2Ddeb89cdc80122136-26q-3D1-26e-3D1d1 e9fd4-2D963c-2D4f0c-2D9030-2Dfa571a9724ea-26u-3Dhttps- 253A-252F-252Furldefense.proofpoint.com-252Fv2-252Fur1-253Fu-253Dhttps-2D3A-5F- 5Fprotect2.fireeye.com-5Fv1-5Fur1-2D3Fk-2D3D732408ba-2D2D2cbf304a-2D2D73232c5f- 2D2Daclf6b01744-2D2D5ef3d1b1d5b43c62-2D26q-2D3D1-2D26e-2D3D83d2ee7c-2D2Db93e-2D2D4e2b- 2D2Daa44-2D2Da878fdb13980-2D26u-2D3Dhttps-2D253A-2D252F-2D252Furldefense.proofpoint.com- 2D252Fv2-2D252Fur1-2D253Fu-2D253Dhttps-2D2D3A-2D5F-2D5Fprotect2.fireeye.com-2D5Fv1-2D5Fur1- 2D2D3Fk-2D2D3Da0969eaa-2D2D2Dff0da7e6-2D2D2Da091ba4f-2D2D2DOcc47adca7cc- 2D2D2D592fd7Ode3382016-2D2D26q-2D2D3D1-2D2D26e-2D2D3D6f706ce0-2D2D2De9c6-2D2D2D4b08- 2D2D2Da64c-2D2D2D2f358da88751-2D2D26u-2D2D3Dhttps-2D2D253A-2D2D252F- EFTA00022441

2D2D252Fwww.crowell.com-2D2D252Fprofessionals-2D2D252FGlen-2D2D2DMcGorty-2D2526d- 2D253DDwMFAg-2D2526c-2D253DAnw7wICLFSGyH7zEzIqo-2D2DzgMRy5HE-2D2DAH- 2D2DSibmOy3H7xE-2D2526r-2D253Dz3qSdxmICBzz6GPGylfF-2D2D3-2D5FHq7hsd51K6MsiI28sD12s- 2D2526m-2D253DBxYgAU783n-2D5FMrr2q5wLWEF-2D2DW5qC1NJ5632-2D2DFFn3TIGQ-2D2526s- 2D253DA3m9orwky1J4SA-2D5FCz6rKjUWOTS I MCuNggS1d60Bm8KY-2D2526e-2D253D-2526d- 253DDwMFAg-2526c-253DAnw7wKLFSGyH7zEzIcp-2DzgMRy5HE-2DAH-2DSibmOy3H7xE-2526r- 253Dz3qSdxmICBzz6GPGylfF-2D3-5FHq7hsd51K6MsiI28sD12s-2526m- 253DReH187Lo8GfZx7aE2WwyLLYGICETXifodokdng9nMbyQ-2526s-253Dqj3bDtQjebwMk9-2DnYfY2hN- 2DIORahrvs4Sn4swvICIaPg-2526e-253D%26d%3DDwIGaQ%26c%3DAnw7wKLFSGyH7zEzIqo- zgMRy5HE-AH-SibmOy3H7xE%26r%3Dz3qSdxmKBzz6GPGylfF- 3_Hq7hsd5IK6MsiI28sDI2s%26m%3DICMcMiSv5F7HqY4pQPICPwh7bwGpy3CQPMWkd7Oauvox8%26s%3 DKYEz7ueEz0izq-WC92fvVIcrznzTUtwyjQP99YW9iYlvv%26e%3D> Privileged and Confidential • Attorney-Client Communication • Attorney Work Product This message contains privileged and confidential information. IF IT WAS SENT TO YOU BY MISTAKE, DO NOT READ IT. Instead, please notify the sender (or [email protected]<mailto:[email protected]>) by reply e- mail, and delete this e-mail. Unauthorized dissemination, forwarding or copying of this e-mail is strictly prohibited. COVID- 19 Questions or Concerns? See Crowell & Moring's COVID-19 Resource Center<https://protect2.fireeye.com/vI/url?k=757c0137-2ae739c7-757b25d2-0cc47adc5fd8- 839a7b I 6d7befe52&q= I &e=933a0917-9adb-4b96-b7eb- 545ade9fe2fl &u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps- 3A_protect2.fireeye.com_v I _ur1-3Fk-3D5f9cbc26-2D000784d6-2D5Db98c3-2Dac I f6b0176130- 2D0f48e223e887bfe3-26q-3D I -26e-3D I d I e9fd4-2D963c-2D4f0c-2D9030-2Dfa57 I a9724ea-26u-3Dhttps- 253A-252F-252Furldefense.proofpoint.com-252Fv2-252Fur1-253Fu-253Dhftps-2D3A-5F- 5Fprotect2.fireeye.com-5Fv1-5Fur1-2D3F1c-2D3D7d03656c-2D2D22985d9c-2D2D7d044189- 2D2Daclf6b01744-2D2D3f8d2012a5d3d164-2D26q-2D3D1-2D26e-2D3D83d2ee7c-2D2Db93e-2D2D4e2b- 2D2Daa44-2D2Da878fdb13980-2D26u-2D3DIfttps-2D253A-2D252F-2D252Furldefense.proofpoint.com- 2D252Fv2-2D252Furl-2D253Fu-2D253Dhttps-2D2D3A-2D5F-2D5Fprotect2.fireeye.com-2D5Fv1-2D5Furl- 2D2D3Fk-2D2D3D39e0ff7b-2D2D2D667bc637-2D2D2D39e7db9e-2D2D2D0cc47adca7cc- 2D2D2D282c063807325fl3-2D2D26q-2D2D3D1-2D2D26e-2D2D3D6f706ce0-2D2D2De9c6-2D2D2D4b08- 2D2D2Da64c-2D2D2D2f358da88751-2D2D26u-2D2D3Dhttps-2D2D253A-2D2D252F- 2D2D252Fwvvw.crowell.com-2D2D252FPractices-2D2D252FCoronavirus-2D2D2DCOVID-2D2D2D19- 2D2D2DResource-2D2D2DCenter-2D2526d-2D253DDwMFAg-2D2526c-2D253DAnw7w1CLFSGyH7zEzIqo- 2D2DzgMRy5HE-2D2DAH-2D2DSibmOy3H7xE-2D2526r-2D253Dz3qSdxmICBzz6GPGylfF-2D2D3- 2D5FHq7hsd51K6MsiI28sD12s-2D2526m-2D253DBxYgAU783n-2D5FMrr2q5wLWEF-2D2DW5qCINJ5632- 2D2DFFn3TIGQ-2D2526s-2D253DJZbX1cDG6y1cGIRKYszz I uLhLOznchyGlpbA47ymp8XY-2D2526e- 2D253D-2526d-253DDwMFAg-2526c-253DAnw7wKLFSGyH7zEzIqo-2DzgMRy5HE-2DAH- 2DSibmOy3H7xE-2526r-253Dz3qScanICBzz6GPGylfF-2D3-5FHq7hsd51K6Msi128sDI2s-2526m- 253DReHI87Lo8GfZx7aE2WwyLLYGKETXifodokdng9nMbyQ-2526s- 253DjcwnSODDGRhPAcYH4OUNj9pTjruaF63yPmdKNUxEIMc-2526e- 253D%26d%3DDwIGaQ%26c%3DAnw7wKLFSGyH7zEzIqo-zgMRy5HE-AH- SibmOy3H7xE%26&/03Dz3qSdxmICBzz6GPGylfF- 3_Hq7hsd5IK6MsiI28sDI2s%26m%3DKMcMiSv5F7HqY4pQPICPwh7bwGpy3CQPMWkd7Oauvox8%26s%3 DMNQW)Yo2qxNbvDdMMaqwa88RrQ5PaSZRf2VRmqZnZN4%26e%3D> From: mailto: > Sent: Monday, October 26, 2020 6:19 PM To: McGort Glen Cc: Zelenko. Daniel mailto >; Giffuni, Danielle (USANYS) EFTA00022442

Subject: RE: Wednesdays WebEx External Email Thanks very much, Glen. Let's plan for 1pm on Thursday, 11/12. I will circulate I WebEx invitation shortly. We expect to ask Mr. about his interactions with the U.S. Customs and Border Protection employee who worked in Saint Thomas and who had Mr. listed as I contact in his phone. I expect we will ask for an approximate timeline of when Mr. met and interacted with the nature of those interactions, and any interactions may have had with Epstein (to the best of Mr. knowledge). Best, Assistant United States Attorney Southern District of New York MEINIMINcmailto: > From: McGorty, Glen Sent: Monda October 26. 2020 I I :5N AM To: Cc: Zelenko, Daniel mailto: mailto Subject: RE: Wednesdays WebEx mailto:a> >; Giffuni, Danielle (USANYS) Sony for the delay. Looks like we can do between 11 M. and 2 p.m. on Tuesday, 11/10, or any time on Thursday, 11/12. Let us know if anything in that range will work. So as to make sure Mr. is prepared, can you give us an overview of what you expect to cover? Thanks, Glen Glen G. McGorty I Crowell & Moring LLP Managing Partner, New York Office mailto: I hnps://protect2.fireeye.cornk 1/url?k=d514b2f8- 8a818a08-d5 1396 Id-0cc47adc5fd8-8ff6d7452248522f&q=l&e=933a0917-9adb-4b96-b7eb- 545ade9fe2fl &u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps- 3A_protect2.fireeye.com_vl_ur1-3Fk-3Dbfb67981-2De02d4171-2Dbfb15d64-2Daclf6b0176b0- 2Da5d94de2c6848330-26q-3D1-26e-3D1d1e9fd4-2D963c-2D4f0c-2D9030-2Dfa571a9724ea-26u-3Dhttp- 253A-252F-252Fwww.crowell.com-252F%26d%3DDwIGaQ%26c%3DAnw7wKLFSGyH7zEzIqo- EFTA00022443

zgMRy5HE-AH-SibmOy3H7xE%26r%3Dz3qSchanKBzz6GPGylfF- 3_Hq7hsd5IK6MsiI28sDI2s%26m%3DICMcMiSv5F7HqY4pQPICPwh7bwGpy3CQPMWkd7Oauvox8%26s%3 DlEPJU8ZIcqPhjFVDD0juy-sclEICnThRSppANbL6FKvIg%26e%3D <https://protect2.fireeye.com/v1/url? k=4b440c1b-14df34eb-4b4328fe-0cc47adc5fd8-ae8f712b8acd34a2&q=1&e=933x0917-9adb-4b96-b7eb- 545ade9fe2fl &u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps- 3A_protect2.fireeye.com_vl_ur1-3Fk-3Dd883b625-2D87188ed5-2Dd88492c0-2DacIf6b0176b0- 2D24c3b989f3b7a05f-26q-3D1-26e-3DIdle9fd4-2D963c-2D4ffic-2D9030-2Dfa57 I a9724ea-26u-3Dhttps- 253A-252F-252Furldefense.proofpoint.com-252Fv2-252Fur1-253Fu-253Dhttps-2D3A-5F- 5Fprotect2.fireeye.com-5Fv1-5Fur1-2D3F1c-2D3D41d4lee8-2D2D1e4f2618-2D2D41d33a0d- 2D2Daclf6b01744c-2D2Ddf30e7b9a2d24ae3-2D26q-2D3D1-2D26e-2D3D83d2ee7c-2D2Db93e-2D2D4e2b- 2D2Daa44-2D2Da878fdb13980-2D26u-2D3Dintps-2D253A-2D252F-2D252Furldefense.proofpoint.com- 2D252Fv2-2D252Furl-2D253Fu-2D253Dhttps-2D2D3A-2D5F-2D5Fprotect2.fireeye.com-2D5Fv1-2D5Furl- 2D2D3Fk-2D2D3D156d4d61-2D2D2D4af6742d-2D2D2D156a6984-2D2D2D0cc47adca7cc- 2D2D2Dle098c3b1c62e4d6-2D2D26q-2D2D3D1-2D2D26e-2D2D3D6f706ce0-2D2D2De9c6-2D2D2D4b08- 2D2D2Da64c-2D2D2D2f358da88751-2D2D26u-2D2D3Dhttps-2D2D253A-2D2D252F- 2D2D252Furldefense.proofpoint.com-2D2D252Fv2-2D2D252Fur1-2D2D253Fu-2D2D253Dhrips-2D2D2D3A- 2D2D5F-2D2D5Fprotect2.fireeye.com-2D2D5Fv1-2D2D5Fur1-2D2D2D3Fk-2D2D2D3D0b835c74- 2D2D2D2D57ed4307-2D2D2D2D0b847891-2D2D2D2D0cc47adca7d0-2D2D2D2D793b46fccdfe879e- 2D2D2D26q-2D2D2D3D1-2D2D2D26e-2D2D2D3Dbafd0b72-2D2D2D2D7c73-2D2D2D2D4779- 2D2D2D2Db589-2D2D2D2De5f94cc4ad85-2D2D2D26u-2D2D2D3Dhttp-2D2D2D253A-2D2D2D252F- 2D2D2D252Fvvww.crowell.com-2D2D2D252F-2D2D2526d-2D2D253DDwMFAg-2D2D2526c- 2D2D253DAnw7w1CLFSGyH7zEzIqo-2D2D2DzgMRy5HE-2D2D2DAH-2D2D2DSibmOy3H7xE- 2D2D2526r-2D2D253DzIgSdxmICBzz6GPGylfF-2D2D2D3-2D2D5FHq7hsd51K6MsiI28sDI2s-2D2D2526m- 2D2D253DLiRaMVPCZ4Z0McIhMm1Gp6sWcyImVIUzlyddWYOaD5c-2D2D2526s- 2D2D253D99IW3XWEOhS2JnRKmzLOWH7Bn3qMaFRjzkibuOeIgx0-2D2D2526e-2D2D253D-2D2526d- 2D253DDwMFAg-2D2526c-2D253DAnw7wICLFSGyH7zEzIqo-2D2DzgMRy5HE-2D2DAH- 2D2DSibmOy3H7xE-2D2526r-2D253DzIgSdxmICBzz6GPGylfF-2D2D3-2D5FHq7hsd51K6MsiI28sDI2s- 2D2526m-2D253DBxYgAU783n-2D5FMrr2q5wLWEF-2D2DW5qCINJ5632-2D2DFFn3TIGQ-2D2526s- 2D253D2001PnMjItTjWidICRroW I upum6GpqYjfW7Jde21Cxws-2D2526e-2D253D-2526d-253DDwMFAg- 2526c-253DAnw7w1CLFSGyH7zEzIqo-2DzgMRy5HE-2DAH-2DSibmOy3H7xE-2526r- 253Dz3ciSccmICBzz6GPGylfF-2D3-5FHq7hsd51K6Msi128sDI2s-2526m- 253DReH187Lo8GfZx7aE2WwyLLYGKET3Cifodokdng9nMbyQ-2526s-253DaA9YCkv-5Fc- 5Fx9O1bMdqrgZ3C5L-2DDY-5F87xkWwg-2Dpmp3nvY-2526e- 253D%26d%3DDwIGaQ%26c%3DAnw7wKLFSGyH7zEzIqo-zgMRy5HE-AH- SibmOy3H7xE%26&/03Dz3ciSdxmICBzz6GPGylfF- 3_Hq7hsd5IK6MsiI28sDI2s%26m%3DICMcMiSv5F7HqY4pQPICPwh7bwGpy3CQPMWkd7Oauvox8%26s%3 D6MbPUaH7x1HOnRFsCdqxgZP6MHeT8SD515vVfczOwfQ%26e%3D> I Web Bio<https://protect2.fireeye.com/v1/url?k=deb3b653-81288ea3-deb492136-0cc47adc5fd8- 5023ef04dcf28248&q=1&e=933a0917-9adb-4b96-b7eb- 545ade9fe2fl 8w=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps- 3A_protect2.fireeye.com_vl_ur1-3Fk-3Db720379f-2De8bb0f6f-2Db727137a-2Daclf6b0176b0- 2D38fddca2d757d27e-26q-3D1-26e-3DIdle9fd4-2D963c-2D4f0c-2D9030-2Dfa571a9724ea-26u-3Dhttps- 253A-252F-252Furldefense.proofpoint.com-252Fv2-252Fur1-253Fu-253Dhttps-2D3A-5F- 5Fprotect2. fireeye.com-5Fv1-5Fur1-2D3Fk-2D3D3fef3d31-2D2D607405c1-2D2D3fe819d4- 2D2Daclf6b01744c-2D2D6f74f26e010ba3fc-2D26q-2D3D1-2D26e-2D3D83d2ee7c-2D2Db93e-2D2D4e2b- 2D2Daa44-2D2Da878fdb13980-2D26u-2D3Dhttps-2D253A-2D252F-2D252Furldefense.proofpoint.com- 2D252Fv2-2D252Furl-2D253Fu-2D253Dhttps-2D2D3A-2D5F-2D5Fprotect2. fireeye.com-2D5Fv1-2D5Fur1- 2D2D3Fk-2D2D3Ddb50db44-2D2D2D84cbe208-2D2D2Ddb57ffal-2D2D2D0cc47adca7cc- 2D2D2D16b127d3e6 I fe9dd-2D2D26q-2D2D3D1-2D2D26e-2D2D3D6f706ce0-2D2D2De9c6-2D2D2D4b08- 2D2D2Da64c-2D2D2D2f358da88751-2D2D26u-2D2D3Dhttps-2D2D253A-2D2D252F- 2D2D252Furldefense.proofpoint.com-2D2D252Fv2-2D2D252Fur1-2D2D253Fu-2D2D253Dhrips-2D2D2D3A- 2D2D5F-2D2D5Fprotect2.fireeye.com-2D2D5Fv1-2D2D5Fur1-2D2D2D3Fk-2D2D2D3D97660208- 2D2D2D2Dcb081d7b-2D2D2D2D976126ed-2D2D2D2D0cc47adca7d0-2D2D2D2Dfa83abbd2707ecc6- 2D2D2D26q-2D2D2D3D1-2D2D2D26e-2D2D2D3Dbafd0b72-2D2D2D2D7c73-2D2D2D2D4779- EFTA00022444

2D2D2D2Db589-2D2D2D2De5f94cc4ad85-2D2D2D26u-2D2D2D3Dhttps-2D2D2D253A-2D2D2D252F- 2D2D2D252Fwww.crowell.com-2D2D2D252Fprofessionals-2D2D2D252FGlen-2D2D2D2DMcGorty- 2D2D2526d-2D2D253DDwMFAg-2D2D2526c-2D2D253DAnw7wKLFSGyH7zEzIgo-2D2D2DzgMRy5HE- 2D2D2DAH-2D2D2DSibmOy3H7xE-2D2D2526r-2D2D253Dz3gSdxmKBzz6GPGylfF-2D2D2D3- 2D2D5FHg7hsd5IK6MsiI28sDl2s-2D2D2526m- 2D2D253DLiRaMVPCZ4Z0McIhMmIGp6sWcyImV I UzlyddWYOaD5c-2D2D2526s- 2D2D253DoupdUqZ8sgwub3VOoJBJahq4X6o48dBlkulABomm4-2D2D2526e-2D2D253D-2D2526d- 2D253DDwMFAg-2D2526c-2D253DAnw7wKLFSGyH7zEzIqo-2D2DzgMRy5HE-2D2DAH- 2D2DSibmOy3H7xE-2D2526r-2D253Dz3qSdxmICBzz6GPGylfF-2D2D3-2D5FHq7hsd51K6Msil28sD12s- 2D2526m-2D253DBxYgAU783n-2D5FMrr2q5wLWEF-2D2DW5qCINJ5632-2D2DFFn3TIGQ-2D2526s- 2D253DppMgYYygel3oioxQMPVFwYlktn-2D2DhzNadE9-2D2DTSASzDMU-2D2526e-2D253D-2526d- 253DDwMFAg-2526c-253DAnw7wKLFSGyH7zEzlqo-2DzgMRy5HE-2DAH-2DSibmOy3H7xE-2526r- 253Dz3qSdxmICBzz6GPGylfF-2D3-5FHq7hsd51K6Msi128sD12s-2526m- 253DReH I 87Lo8Gfa7aE2WwyLLYGICET3Cifodokdng9nMbyQ-2526s-253Dt9IMaD7v1hBeS2Gowlko- 2DCzGeV09C1pUJFu7qRVICP9Y-2526e-253D%26d%3DDwIGaQ%26c%3DAnw7wKLFSGyH7zEzIqo- zgMRy5HE-AH-SibmOy3H7xE%26r%3Dz3qSdianKBzz6GPGylfF- 3_Hq7hsd5IK6Msil28sDI2s%26m%3DICMcMiSv5F7HqY4pQPICPwh7bwGpy3CQPMWkd7Oauvox8%26s%3 Dt4UWitiN_BYtgjf7MysQAP2qgRZfcimKQ7kyripSi2c%26e%3D> Privileged and Confidential • Attorney-Client Communication • Attorney Work Product This message contains privileged and confidential information. IF IT WAS SENT TO YOU BY MISTAKE, DO NOT READ IT. Instead, please notify the sender (or [email protected]<mailto:[email protected]>) by reply e- mail, and delete this e-mail. Unauthorized dissemination, forwarding or copying of this e-mail is strictly prohibited. COVID- 19 Questions or Concerns? See Crowell & Moring's COVID-19 Resource Center<https://protect2.fireeye.com/v1/url?k=ca66e66e-95fdde9e-ca61c28b-Occ47adc5fd8- 0701355e6d5b6c049&q=l&e-933a0917-9adb-41396-b7eb- 545ade9fe2fl &u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps- 3A_protect2.fireeye.com_v I _ur1-3Fk-3D222Iea22-2D7dbad2d2-2D2226cec7-2Dacl f6b0176b0- 2D2fe6b94cef28da89-26q-3D1-26e-3D1d1e9fd4-2D963c-2D4f0c-2D9030-2Dfa571a9724ea-26u-3Dhttps- 253A-252F-252Furldefense.proofpoint.com-252Fv2-252Fur1-253Fu-253Dhttps-2D3A-5F- 5Fprotect2. fireeye.com-5Fv1-5Fur1-2D3Fk-2D3Df440aldc-2D2Dabdb992c-2D2Df4478539- 2D2Daclf6b01744c-2D2D919afb025125fc70-2D26q-2D3D1-2D26e-2D3D83d2ee7c-2D2Db93e-2D2D4e2b- 2D2Daa44-2D2Da878fdb13980-2D26u-2D3Dhttps-2D253A-2D252F-2D252Furldefense.proofpoint.com- 2D252Fv2-2D252Fur1-2D253Fu-2D253Dhttps-2D2D3A-2D5F-2D5Fprotect2.fireeye.com-2D5Fv1-2D5Fur1- 2D2D3Fk-2D2D3D7838f5b7-2D2D2D27a3ccfb-2D2D2D783fd152-2D2D2DOcc47adca7cc- 2D2D2Db79227ebd013097c-2D2D26q-2D2D3D1-2D2D26e-2D2D3D61706ce0-2D2D2De9c6-2D2D2D4b08- 2D2D2Da64c-2D2D2D2f358da88751-2D2D26u-2D2D3Dhttps-2D2D253A-2D2D252F- 2D2D252Furldefense.proofpoint.com-2D2D252Fv2-2D2D252Fur1-2D2D253Fu-2D2D253Dhttps-2D2D2D3A- 2D2D5F-2D2D5Fprotect2.fireeye.com-2D2D5Fv1-2D2D5Fur1-2D2D2D3Fk-2D2D2D3D0e881fa7- 2D2D2D2D52e600d4-2D2D2D2D0e8f3b42-2D2D2D2DOcc47adca7d0-2D2D2D2D602eb0f7e2ab0811- 2D2D2D26q-2D2D2D3D1-2D2D2D26e-2D2D2D3Dbafd0b72-2D2D2D2D7c73-2D2D2D2D4779- 2D2D2D2Db589-2D2D2D2De5194cc4ad85-2D2D2D26u-2D2D2D3Dhttps-2D2D2D253A-2D2D2D252F- 2D2D2D252Fvvww.crowell.com-2D2D2D252FPractices-2D2D2D252FCoronavirus-2D2D2D2DCOVID- 2D2D2D2D19-2D2D2D2DResource-2D2D2D2DCenter-2D2D2526d-2D2D253DDwMFAg-2D2D2526c- 2D2D253DAnw7w1CLFSGyH7zEzlqo-2D2D2DzgMRy5HE-2D2D2DAH-2D2D2DSibm0y3H7xE- 2D2D2526r-2D2D253Dz3qSdxmICBzz6GPGylfF-2D2D2D3-2D2D5FHq7hsd51K6Msil28sD12s-2D2D2526m- 2D2D253DLiRaMVPCZ4Z0McIhMmIGp6sWcyImV I UzlyddWYOaD5c-2D2D2526s- 2D2D253DQfDimRPsTg2CdtAGM1Hz I YypBIRSDR-2D2D5FWUrWbvatipVY-2D2D2526e-2D2D253D- 2D2526d-2D253DDwMFAg-2D2526c-2D253DAnw7w1CLFSGyH7zEzIqo-2D2DzgMRy5HE-2D2DAH- 2D2DSibmOy3H7xE-2D2526r-2D253Dz3qSdxmICBzz6GPGylfF-2D2D3-2D5FHq7hsd51K6Msil28sD12s- 2D2526m-2D253DBxYgAU783n-2D5FMrr2q5wLWEF-2D2DW5qCINJ5632-2D2DFFn3TIGQ-2D2526s- 2D253DENBlarr0CCufuWoJGEAgTJgAC37R78ILuHP75RshUHyAw-2D2526e-2D253D-2526d- EFTA00022445

253DDwMFAg-2526c-253DAnw7wKLFSGyH7zEzIqo-2DzgMRy5HE-2DAH-2DSibmOy3H7xE-2526r- 253Dz3qSdxmICBzz6GPGylfF-2D3-5FHq7hsd51K6Msi128sDI2s-2526m- 253DReH187Lo8GfZx7aE2WwyLLYGKETXifodokdng9nMbyQ-2526s-253DrNJ0fcA4DmP6v- 2DLanqWQLToaJ-2D5gCKcrjX-2DhBWEeZvg-2526e- 253D%26d%3DDwIGaQ%26c%3DAnw7wKLFSGyH7zEzlqo-zgMRy5HE-AH- SibmOy3H7xE%26&/03Dz3qSdxmKEzz6GPGylfF- 3_Hq7hsd5IK6Msil28sDI2s%26m%3DICMcMiSv5F7HqY4pQPKPwh7bwGpy3CQPMWkd7Oauvox8%26s%3 D3bpaIcOJpplbU_IT2KMC-rnHb_EZuywFGXt5dR9HZbJM%26e%3D> From: MI=IMMIM c ilME<mailto:a> Sent: Thursda October 22, 2020 10:33 AM To: Cc: Zelenko, Daniel ">; Giffuni, Danielle mailto: mailto Subject: RE: Wednesdays WebEx External Email Glen, As I believe we mentioned when we last spoke, we would like to schedule time for a second interview with Mr. via WebEx. Are there any days the week of November 9th when your team and Mr. would be available? We would expect this proffer to be much shorter than our first, and certainly no more than two hours at most. Thanks, Assistant United States Attorney Southern District of New York mailto: From: l== / alMIE<mailto:MIMME>> Sent: Friday, October 9 2020 4:42 PM To: McGorty, Glen • mailto: Cc: Zelenko, Daniel mailto mailto: mailto mailto: Subject: RE: Wednesdays WebEx Hi Glen, Thanks very much. I'm attaching the fully executed copy. Thanks, >; Giffuni, Danielle EFTA00022446